HomeIDXG • OTCMKTS
add
Interpace Biosciences Inc
Previous close
$0.81
Day range
$0.87 - $0.92
Year range
$0.44 - $3.54
Market cap
3.96M USD
Avg Volume
13.80K
P/E ratio
1.03
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 11.52M | 12.09% |
Operating expense | 5.54M | 6.62% |
Net income | 1.65M | 251.92% |
Net profit margin | 14.30 | 213.60% |
Earnings per share | — | — |
EBITDA | 1.92M | 107.78% |
Effective tax rate | 1.02% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.20M | -57.47% |
Total assets | 14.49M | 19.37% |
Total liabilities | 15.08M | -43.63% |
Total equity | -582.00K | — |
Shares outstanding | 4.54M | — |
Price to book | -6.23 | — |
Return on assets | 31.23% | — |
Return on capital | 132.50% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 1.65M | 251.92% |
Cash from operations | 1.24M | 2,229.31% |
Cash from investing | — | — |
Cash from financing | -1.50M | -150.00% |
Net change in cash | -265.00K | 61.37% |
Free cash flow | 1.12M | 2,146.35% |
About
Founded
1986
Headquarters
Website
Employees
111
